由于用ECMO和CRRT治疗的卡佩西塔毒性症导致心脏骤停:一个病例报告
Liqin Zhang1, Mingjun Liu2, Lutao Xie3
1Liqin Zhang is a resident physician in the Department of Intensive Care Medicine, Lishui Municipal Central Hospital, Lishui City, Zhejiang Province, China.
Critical care nurse
|July 31, 2024
概括
这份病例报告详细介绍了一位患有卡皮西塔化疗引起心脏性休克的患者. 静脉外体膜氧化和持续的置换疗法导致了完全康复.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 卡佩奇他是一种口服化疗剂,用于治疗各种恶性瘤.
- 心脏性休克是一种罕见但严重的不良事件,与capecitabine治疗有关.
研究的目的:
- 在口服capecitabine化疗后报告第一个心脏性休克病例.
- 描述结合体外膜氧化和连续脏替代疗法在治疗这种并发症中的成功使用.
主要方法:
- 一名患有直肠恶性瘤的58岁男性患者接受了口服capecitabine.
- 患者出现了快速发作的心律失常,进展为心脏性休克和心脏骤停.
- 治疗包括静脉外体膜氧化 (VA-ECMO) 和连续置换疗法 (CRRT).
主要成果:
- 患者在服用capecitabine后经历了心脏骤停.
- 联合VA-ECMO和CRRT作为救命干预措施开始实施.
- 患者完全康复,并从医院出院.
结论:
- 包括VA-ECMO和CRRT在内的综合性支持性护理对于卡佩西塔引起的心脏骤停的患者来说可能至关重要.
- 这些疗法有助于快速降低药物度和消除有毒物质.
- 这种方法显著改善了与化疗相关的严重心脏事件的患者预后.
相关概念视频
Drug Toxicity: Overview
256
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
256
Drug Toxicity: Risk factors
213
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
213
Drug Toxicity: Dose-Dependent Reactions
211
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
211
Drug toxicity: Idiosyncratic Reactions
197
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
197
Cardiopulmonary Resuscitation III: AED Use
1.5K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.5K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.5K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.5K


